Literature DB >> 15104540

Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.

Mikhail A Panteleev1, Evgueni L Saenko, Natalya M Ananyeva, Fazoil I Ataullakhanov.   

Abstract

Intrinsic tenase consists of activated Factors IX (IXa) and VIII (VIIIa) assembled on a negatively charged phospholipid surface. In vivo, this surface is mainly provided by activated platelets. In vitro, phosphatidylcholine/phosphatidylserine vesicles are often used to mimic natural pro-coagulant membranes. In the present study, we developed a quantitative mathematical model of Factor X activation by intrinsic tenase. We considered two situations, when complex assembly occurs on either the membrane of phospholipid vesicles or the surface of activated platelets. On the basis of existing experimental evidence, the following mechanism for the complex assembly on activated platelets was suggested: (i) Factors IXa, VIIIa and X bind to their specific platelet receptors; (ii) bound factors form complexes on the membrane: platelet-bound Factor VIIIa provides a high-affinity site for Factor X and platelet-bound Factor IXa provides a high-affinity site for Factor VIIIa; (iii) the enzyme-cofactor-substrate complex is assembled. This mechanism allowed the explanation of co-operative effects in the binding of Factors IXa, VIIIa and X to platelets. The model was reduced to obtain a single equation for the Factor X activation rate as a function of concentrations of Factors IXa, VIIIa, X and phospholipids (or platelets). The equation had a Michaelis-Menten form, where apparent V(max) and K(m) were functions of the factors' concentrations and the internal kinetic constants of the system. The equation obtained can be used in both experimental studies of intrinsic tenase and mathematical modelling of the coagulation cascade. The approach of the present study can be applied to research of other membrane-dependent enzymic reactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104540      PMCID: PMC1133888          DOI: 10.1042/BJ20031748

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  Biochemistry and physiology of blood coagulation.

Authors:  K G Mann
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.

Authors:  F S London; P N Walsh
Journal:  Biochemistry       Date:  2000-08-15       Impact factor: 3.162

3.  The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.

Authors:  Frank H Wilkinson; Syed S Ahmad; Peter N Walsh
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

4.  Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.

Authors:  Syed S Ahmad; Peter N Walsh
Journal:  Biochemistry       Date:  2002-09-17       Impact factor: 3.162

5.  Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.

Authors:  A L Kuharsky; A L Fogelson
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

Review 6.  Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex.

Authors:  E L Saenko; M Shima; A G Sarafanov
Journal:  Trends Cardiovasc Med       Date:  1999-10       Impact factor: 6.677

7.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

8.  Contribution of erythrocytes to thrombin generation in whole blood.

Authors:  V Peyrou; J C Lormeau; J P Hérault; C Gaich; A M Pfliegger; J M Herbert
Journal:  Thromb Haemost       Date:  1999-03       Impact factor: 5.249

9.  Hemophilia A and B are associated with abnormal spatial dynamics of clot growth.

Authors:  Mikhail V Ovanesov; Julya V Krasotkina; Ljudmila I Ul'yanova; Kema V Abushinova; Olga P Plyushch; Sergey P Domogatskii; Andrey I Vorob'ev; Fazly I Ataullakhanov
Journal:  Biochim Biophys Acta       Date:  2002-08-15

10.  Interaction of bovine coagulation factor X and its glutamic-acid-containing fragments with phospholipid membranes. A surface plasmon resonance study.

Authors:  Eva-Maria Erb; Johan Stenflo; Torbjörn Drakenberg
Journal:  Eur J Biochem       Date:  2002-06
View more
  5 in total

1.  Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively.

Authors:  Mikhail A Panteleev; Mikhail V Ovanesov; Dmitrii A Kireev; Aleksei M Shibeko; Elena I Sinauridze; Natalya M Ananyeva; Andrey A Butylin; Evgueni L Saenko; Fazoil I Ataullakhanov
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

2.  Thrombin activity propagates in space during blood coagulation as an excitation wave.

Authors:  N M Dashkevich; M V Ovanesov; A N Balandina; S S Karamzin; P I Shestakov; N P Soshitova; A A Tokarev; M A Panteleev; F I Ataullakhanov
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

3.  Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.

Authors:  Ansar S Zhalyalov; Mikhail A Panteleev; Marina A Gracheva; Fazoil I Ataullakhanov; Alexey M Shibeko
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

4.  Phosphatidylserine's role in Ebola's inflammatory cytokine storm and hemorrhagic consumptive coagulopathy and the therapeutic potential of annexin V.

Authors:  James R Kennedy
Journal:  Med Hypotheses       Date:  2019-10-28       Impact factor: 1.538

5.  SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.

Authors:  Kenneth C Childers; Shaun C Peters; Pete Lollar; Harold Trent Spencer; Christopher B Doering; Paul C Spiegel
Journal:  Blood Adv       Date:  2022-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.